A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients

Cancer Investigation

Volumn 5, Issue 4, 1987, Pages 267-273

  Vogler, William R ^a   Malcom, Lisa G ^a   Winton, Elliott F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; NYSTATIN;

CANCER CHEMOTHERAPY; CANDIDIASIS; LEUKEMIA; MYCOSIS; NEUTROPENIA; PROPHYLAXIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; CANDIDIASIS, ORAL; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNE TOLERANCE; KETOCONAZOLE; LEUKEMIA; MALE; MIDDLE AGE; NEUTROPENIA; NYSTATIN; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023609263     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1080/07357908709170099     Document Type: Article

References (18)

1. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients
2. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
3. Candidiasis in cancer patients
4. Oral amphotericin for candidiasis in patients with hematologic neoplasms
5. Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis
6. Ketoconazole, an oral antifungal: Laboratory and clinical assessment of imidazole drugs
7. Mechanism of action of antifungal drugs, with specific reference to the imidazole derivatives
8. Antifungal chemotherapy
9. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients
10. Infection prevention in acute nonlymphocytic leukemia (laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis)
11. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases
12. Granulocyotpenia in hospitalized patients. I. Prognostic factors and etiology of fever
13. Opportunistic fungal infections in patients with neoplastic disease
14. Antibiotics in patients with neutropenia
15. Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality
16. Systemic candidiasis in cancer patients
17. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients
18. Randomized trial of high-dose ketoconazole (KETO) or nystatin (NYS) as fungal prophylaxis during intensive chemotherapy